E2 Dispensing is part of the RxE2’s decentralized clinical trial research platform, which makes clinical trial enrollment possible for everyone, everywhere. Fargo, North Dakota, and London, UK July 29, 2020 — RxE2 and Newdays Pharmacy have launched the first pharmacy dispensing services for clinical drug trials in the European Union and the United Kingdom. This…
Fargo, ND, July 15, 2020 — RxE2 announced today the appointment of Tina Schlecht, Pharm. D. as the company’s Vice President of Pharmacy Operations. Tina Schlecht, Pharm. D., Vice President ofPharmacy Operations, RxE2 In this role, Dr. Schlecht will be responsible for: Onboarding new pharmacies worldwide to RxE2’s decentralized clinical research platform Overseeing the company’s…
E2 Dispensing, part of the RxE2’s decentralized clinical trial platform, provides an adaptable, simplified, cost effective, state pharmacy regulation abiding alternative to traditional packaging, labeling and dispensing processes. Fargo, North Dakota, June 25, 2020 — Pharma companies with drugs in clinical development can now easily, cost effectively and legally reach ALL qualifying clinical trial patients…